作者:
Jabbour,E. [1]
;
Kantarjian,H.M. [2]
;
Saglio,G. [3]
;
Steegmann,J.L. [4]
;
Shah,N.P. [5]
;
Boqué,C. [6]
;
Chuah,C. [7]
;
Pavlovsky,C. [8]
;
Mayer,J. [9]
;
Cortes,J. [10]
;
Baccarani,M. [11]
;
Kim,D.-W. [12]
;
Bradley-Garelik,M.B. [13]
;
Mohamed,H. ;
Wildgust,M. ;
Hochhaus,A.
作者单位:
University of California, San Francisco School of Medicine, San Francisco, CA, United States
[1]
Department of Clinical Hematology, Institut Català d'Oncologia, Hospitalet de Llobregat, Barcelona
[2]
University of Texas M.D. Anderson Cancer Center, Department of Leukemia, 1515 Holcombe Blvd
[3]
Fundación Para Combatir la Leucemia, Angelica Ocampo Hospitalization and Clinical Research Center
[4]
Bristol-Myers Squibb, Princeton, NJ, United States
[5]
Singapore General Hospital, Duke-National University of Singapore, Graduate Medical School
[6]
Bristol-Myers Squibb, Wallingford, CT, United States
[7]
Universit?tsklinikum Jena, Jena, Germany
[8]
Catholic University of Korea, Seoul, South Korea
[9]
Hospital de la Princesa, Madrid, Spain
[10]
University of Bologna, Bologna, Italy
[11]
University of Torino, Ospedale San Luigi Gonzaga, Orbassano-Torino, Italy
[12]
University Hospital Brno, Central European Institute of Technology, Masaryk University, Brno, Czech
[13]
发布时间
2014-04-03